Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tofacitinib in De Novo Kidney Transplant
NCT00483756Phase 2Completed
- Sponsor
- Pfizer
- Start
- Aug 2007
- Primary completion
- Feb 2010
- Modality
- Small Molecules
- Countries
- 15
01
Overview
A Phase 2 trial of tofacitinib in kidney transplant rejection, sponsored by Pfizer. Started Aug 2007; status: completed.
02
Drugs
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00483756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00483756.